Histopathological components correlated with MRI features and prognosis in combined hepatocellular carcinoma-cholangiocarcinoma

Sciarra A, Park YN, Sempoux C (2020) Updates in the diagnosis of combined hepatocellular-cholangiocarcinoma. Hum Pathol 96:48–55

CAS  Article  Google Scholar 

Garancini M, Goffredo P, Pagni F et al (2014) Combined hepatocellular-cholangiocarcinoma: a population-level analysis of an uncommon primary liver tumor. Liver Transpl 20:952–959

Article  Google Scholar 

Sempoux C, Kakar S, Kondo F, Schirmacher P (2019) Combined hepatocellular-cholangiocarcinoma. In: Bosman FT, Carneiro F, Hruban RH, Theise ND (eds) WHO classification of tumours: digestive system tumours, vol 2019, 5th edn. IARC, Lyon, pp 260–262

Google Scholar 

Nagtegaal ID, Odze RD, Klimstra D et al (2020) The 2019 WHO classification of tumours of the digestive system. Histopathology 76:182–188

Article  Google Scholar 

Zhou CW, Wang Y, Ma L, Qian XL, Yang C, Zeng MS (2022) Combined hepatocellular carcinoma-cholangiocarcinoma: MRI features correlated with tumor biomarkers and prognosis. Eur Radiol 32:78–88

Article  Google Scholar 

Gera S, Ettel M, Acosta-Gonzalez G, Xu R (2017) Clinical features, histology, and histogenesis of combined hepatocellular-cholangiocarcinoma. World J Hepatol 9:300–309

Article  Google Scholar 

Shetty AS, Fowler KJ, Brunt EM, Agarwal S, Narra VR, Menias CO (2014) Combined hepatocellular-cholangiocarcinoma: what the radiologist needs to know about biphenotypic liver carcinoma. Abdom Imaging 39:310–322

Article  Google Scholar 

Yin X, Zhang BH, Qiu SJ et al (2012) Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis. Ann Surg Oncol 19:2869–2876

Article  Google Scholar 

Chok KSH, Ng KKC, Cheung TT et al (2009) An update on long-term outcome of curative hepatic resection for hepatocholangiocarcinoma. World J Surg 33:1916–1921

Article  Google Scholar 

Jarnagin WR, Weber S, Tickoo SK et al (2002) Combined hepatocellular and cholangiocarcinoma: demographic, clinical, and prognostic factors. Cancer 94:2040–2046

Article  Google Scholar 

Jiang XX, Huang XT, Huang CS, Chen LH, Liang LJ, Yin XY (2020) Long-term outcome and prognostic factors of combined hepatocellular carcinoma and cholangiocarcinoma after curative resection. Gastroenterol Rep 8:134–142

Article  Google Scholar 

Wang XL, Wang WT, Ma XJ et al (2020) Combined hepatocellular-cholangiocarcinoma: which preoperative clinical data and conventional MRI characteristics have value for the prediction of microvascular invasion and clinical significance? Eur Radiol 30:5337–5347

Article  Google Scholar 

Zhou CW, Ni XY, Lu X et al (2021) MR features based on LI-RADS ver. 2018 correlated with cytokeratin 19 expression in combined hepatocellular carcinoma-cholangiocarcinoma. J Hepatocell Carcinoma 8:975–983

Article  Google Scholar 

Choi SH, Lee SS, Park SH et al (2019) LI-RADS classification and prognosis of primary liver cancers at gadoxetic acid-enhanced MRI. Radiology 290:388–397

Article  Google Scholar 

Choi SH, Jeon SK, Lee SS et al (2021) Radio-pathologic correlation of biphenotypic primary liver cancer (combined hepatocellular cholangiocarcinoma): changes in the 2019 WHO classification and impact on LI-RADS classification at liver MRI. Eur Radiol 31:9479–9488

Article  Google Scholar 

Stavraka C, Rush H, Ross P (2019) Combined hepatocellular cholangiocarcinoma (cHCC-CC): an update of genetics, molecular biology, and therapeutic interventions. J Hepatocell Carcinoma 6:11–21

CAS  Article  Google Scholar 

Maximin S, Ganeshan DM, Shanbhogue AK et al (2014) Current update on combined hepatocellular-cholangiocarcinoma. Eur J Radiol Open 1:40–48

Article  Google Scholar 

Mazzaferro V, Llovet JM, Miceli R et al (2009) Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol 10:35–43

Article  Google Scholar 

Jeon SK, Joo I, Lee DH et al (2019) Combined hepatocellular cholangiocarcinoma: LI-RADS v2017 categorisation for differential diagnosis and prognostication on gadoxetic acid-enhanced MR imaging. Eur Radiol 29:373–382

Article  Google Scholar 

He C, Mao Y, Wang J et al (2018) The predictive value of staging systems and inflammation scores for patients with combined hepatocellular cholangiocarcinoma after surgical resection: a retrospective study. J Gastrointest Surg 22:1239–1250

Article  Google Scholar 

Park SH, Lee SS, Yu E et al (2017) Combined hepatocellular-cholangiocarcinoma: gadoxetic acid-enhanced MRI findings correlated with pathologic features and prognosis. J Magn Reson Imaging 46:267–280

Article  Google Scholar 

留言 (0)

沒有登入
gif